“Burst” Ketamine for Refractory Cancer Pain
- 1 October 2001
- journal article
- research article
- Published by Elsevier in Journal of Pain and Symptom Management
- Vol. 22 (4) , 834-842
- https://doi.org/10.1016/s0885-3924(01)00340-2
Abstract
No abstract availableKeywords
This publication has 18 references indexed in Scilit:
- Low-dose subcutaneous ketamine infusion and morphine tolerancePain, 1999
- Oral Ketamine and Transdermal Nitroglycerin as Analgesic Adjuvants to Oral Morphine Therapy for Cancer Pain ManagementAnesthesiology, 1999
- The visual analogue pain intensity scale: what is moderate pain in millimetres?Pain, 1997
- Validation of World Health Organization Guidelines for cancer pain relief: a 10-year prospective studyPain, 1995
- Spinal cord pharmacology of painBritish Journal of Anaesthesia, 1995
- Somatic pain–pathogenesis and preventionBritish Journal of Anaesthesia, 1995
- A prospective multicenter assessment of the Edmonton staging system for cancer painJournal of Pain and Symptom Management, 1995
- Ketamine as an adjunct to morphine in the treatment of painPain, 1995
- The Role of Ketamine, an NMDA Receptor Antagonist, in the Management of PainProgress in Palliative Care, 1995
- Continuous subcutaneous injection of ketamine for cancer painCanadian Journal of Anesthesia/Journal canadien d'anesthésie, 1990